Skip to content

Usefulness of inhalation therapy using inhalation support program for hospitalized asthma and COPD patients

Usefulness of inhalation therapy using inhalation support program for hospitalized asthma and COPD patients - Usefulness of inhalation therapy using inhalation support program for hospitalized asthma and COPD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038453
Enrollment
60
Registered
2019-10-31
Start date
2017-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma and COPD

Interventions

Group B (other ward hospitalization group): Intervention based on usual medication guidance will be conducted, and at the time of the first interview and discharge, a questionnaire and ACT, CAT, ASK20

Sponsors

Clinical Research Review Committee of Mitoyo General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who can use inhaled drugs by themselves Patients who are judged as asthma or COPD by the attending physician and have a medical record to that effect Patients who are 16 years of age or older when obtaining consent Patients who can cooperate in questionnaire surveys at the time of hospitalization and discharge, and 3 months after discharge Patients who have received sufficient explanation for participation in this study, and have obtained sufficient consent and consent from their own will

Exclusion criteria

Exclusion criteria: Patients who cannot use inhaled drugs by themselves Patients with unknown pathological conditions such as asthma and COPD Patients who are 15 years old or younger at the time of obtaining consent Patients who cannot cooperate in the questionnaire at the first interview, at the time of discharge, or 3 months after discharge Patients who cannot obtain their own consent Other patients who are determined to be inappropriate as research subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
Degree of comprehension level of understanding of the importance of continuous use 3 months after discharge

Secondary

MeasureTime frame
QOL improvement by drug, disease, technique / understanding Adherence improvement by drug, disease, procedure / understanding Improvement of understanding of proper use of inhaled drugs by drug and disease

Countries

Japan

Contacts

Public ContactHiroshi Shinonaga

Mitoyo General Hospital Pharmaceutical department

shino-ph@mitoyo-hosp.jp0875-52-3366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026